[Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis].
van Deventer
S J
SJ
Academisch Medisch Centrum, afd. Inwendige Geneeskunde, Amsterdam.
van der Linden
C J
CJ
Roord
J J
JJ
Schellekens
H
H
Schellekens
J F
JF
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic / Q000592:standards; D016905:Gram-Negative Bacterial Infections / Q000628:therapy; D006801:Humans; D007075:Immunoglobulin M / Q000627:therapeutic use*; D018805:Sepsis / Q000628:therapy*; D012772:Shock, Septic / Q000628:therapy
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007075:Immunoglobulin M; C068069:nebacumab